Massimo Claudio Fantini Selected Research

Massimo Claudio Fantini Research Topics

Disease

14	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2023 - 01/2007
8	Ulcerative Colitis 12/2023 - 08/2010
8	Inflammation (Inflammations) 12/2023 - 01/2007
7	Crohn Disease (Crohn's Disease) 12/2023 - 06/2009
4	Neoplasms (Cancer) 09/2020 - 06/2008
4	Colitis 01/2018 - 06/2009
4	Colonic Neoplasms (Colon Cancer) 10/2011 - 02/2008
3	Colitis-Associated Neoplasms 05/2021 - 10/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2010 - 02/2008
1	Fistula 01/2023
1	Ageusia (Hypogeusia) 05/2021
1	Anosmia 05/2021
1	Fever (Fevers) 05/2021
1	Infections 05/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Fatty Liver 01/2021
1	Obesity 01/2021
1	Breast Neoplasms (Breast Cancer) 09/2020
1	Melanoma (Melanoma, Malignant) 09/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2020
1	COVID-19 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Venous Thromboembolism 01/2020
1	Carcinogenesis 01/2010
1	Bacterial Infections (Bacterial Infection) 02/2008
1	Hypersensitivity (Allergy) 03/2007

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 12/2023 - 01/2007
5	Adalimumab (Humira)FDA Link 01/2023 - 01/2019
5	Infliximab (Remicade)FDA Link 01/2023 - 01/2019
5	InterleukinsIBA 03/2012 - 01/2007
4	vedolizumabIBA 01/2023 - 10/2019
4	interleukin-21 (interleukin 21)IBA 10/2011 - 01/2007
4	Mesalamine (Mesalazine)FDA LinkGeneric 10/2011 - 02/2008
3	Interleukin-17 (Interleukin 17)IBA 10/2011 - 02/2008
2	AntigensIBA 12/2023 - 09/2020
2	Ustekinumab (CNTO 1275)FDA Link 01/2023 - 04/2022
2	Monoclonal AntibodiesIBA 01/2023 - 09/2020
2	golimumab FDA Link 04/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2008
2	Interleukin-13IBA 03/2012 - 06/2009
2	AcidsIBA 03/2012 - 06/2009
2	AzoxymethaneIBA 10/2011 - 01/2010
2	Dextran SulfateIBA 10/2011 - 01/2010
2	2-methoxy-5-amino-N-hydroxybenzamideIBA 10/2011 - 01/2010
1	SuspensionsIBA 01/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	tofacitinibIBA 04/2022
1	Immunoglobulin G (IgG)IBA 05/2021
1	C-Reactive ProteinIBA 01/2021
1	LipidsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021
1	IntegrinsIBA 09/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Biosimilar PharmaceuticalsIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	NAD (NADH)IBA 01/2018
1	Sirtuin 1IBA 01/2018
1	Chemokine CCL20IBA 05/2017
1	Antisense OligonucleotidesIBA 05/2017
1	GED0301IBA 05/2017
1	Interleukin-4 (Interleukin 4)IBA 03/2012
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2012
1	AntibodiesIBA 03/2012
1	Interleukin-6 (Interleukin 6)IBA 10/2011
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2011
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 10/2011
1	SurvivinIBA 10/2011
1	TNF-Related Apoptosis-Inducing LigandIBA 10/2011
1	Interferon-gamma (Interferon, gamma)IBA 08/2010
1	Antineoplastic Agents (Antineoplastics)IBA 01/2010
1	OxazoloneIBA 06/2009
1	Interleukin-12 (IL 12)IBA 06/2009
1	Peptidoglycan (Murein)IBA 06/2009
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2008
1	Dinoprostone (PGE2)FDA Link 02/2008
1	Interleukin-23 (Interleukin 23)IBA 02/2008
1	Interleukin-21 ReceptorsIBA 01/2007

Therapy/Procedure

7	Therapeutics 01/2023 - 10/2011
1	Biological Therapy 05/2021
1	Mediterranean Diet 01/2021
1	Continuous Positive Airway Pressure 01/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Respiratory Therapy (Therapy, Respiratory) 01/2020